Technical Issue 137 Cryptoassets as an Alternative Investment Class for Cayman Islands Alternative Investment Funds Abraham Thoppil, Maples and Calder
Technical Issue 137 Sanctions, Sanctions and More Sanctions! Updates: Iran, Venezuela and Russia Betty Santangelo, Gary Stein, Seetha Ramachandran, Jennifer M. Opheim, Mari S. Dopp and Nicole Geoglis, Schulte Roth & Zabel
Technical Issue 136 The Impact of BEPS on Tax Treaty Relief for Alternative Funds Andrew Quinn and David Burke, Maples and Calder
Technical Issue 135 Short-and-Distort Scheme SEC charges hedge fund manager Craig S. Warkol, Marc E. Elovitz and Brian T. Daly, Schulte Roth & Zabel LLP
Technical Issue 135 Delegation and Oversight The new standards Daniel Capocci (director), Benjamin Collette (partner) & Simon Ramos (partner) – Deloitte Luxembourg
Technical Issue 135 Distressed Debt Investing and Loan to Own Strategies Should a Cayman Islands Scheme of Arrangement be your next play? Caroline Moran and Nick Herrod, Maples and Calder
Technical Issue 134 OCIE Best Execution Risk Alert Guidance and lessons for private fund managers Brian T. Daly and Marc E. Elovitz, Schulte Roth & Zabel LLP
Technical Issue 134 Cybersecurity and the Board’s Responsibilities ‘What’s reasonable has changed’ Christopher P. Skroupa talks to Michael L. Yaeger, Special Counsel, Schulte Roth & Zabel
Technical Issue 134 Senior Managers Certification Regime Are you ready to be held personally accountable? Interview with Priya Mehta and Kimberly Bradshaw, Buzzacott
Technical Issue 133 Are You Coping with the MiFID II Requirements? Stripping out the manual processes from regulatory reporting Deb Marabotti, Business Development Manager, Truss Edge
Technical Issue 133 BDC and RIC Research and Issuance Proliferating Sector flourishing amid liberalisation Hamlin Lovell talks to Washington-based SRZ partner John J. Mahon
Technical Issue 133 Proposals to Strengthen ESMAs Oversight Over Delegation Why you should review your delegation arrangements now Mark Shaw, Partner and Head of London, Wildgen